Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
Acta Pharmacologica Sinica|August 15, 2001
Polymorphism of CYP450 and cancer susceptibilityX M Han, H H ZhouClinical Pharmacology and Therapeutics|August 1, 1991
Increased suppression of exercise-induced increase in renin by propranolol in Chinese subjectsH H Zhou, A J WoodClinical Pharmacology and Therapeutics|August 1, 1992
Differing effect of atropine on heart rate in Chinese and white subjectsH H Zhou, A Adedoyin, A J WoodAnesthesiology|February 1, 1997
Spinal cord motoneuron excitability during isoflurane and nitrous oxide anesthesiaH H Zhou, M Mehta, A A LeisBritish Journal of Clinical Pharmacology|January 1, 1992
Lack of effect of ageing on the stereochemical disposition of propranololH H Zhou, E Whelan, A J WoodClinical Pharmacology and Therapeutics|July 1, 1990
Differences in plasma binding of drugs between Caucasians and Chinese subjectsH H Zhou, A Adedoyin, G R WilkinsonBritish Journal of Clinical Pharmacology|October 1, 1996
In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamineZ H Xu, H G Xie, H H ZhouJournal of Chromatography. B, Biomedical Applications|June 9, 1995
High-performance liquid chromatographic determination of urinary 4'-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humansH G Xie, S L Huang, H H ZhouChinese Medical Journal|December 1, 1993
Contribution of differences in plasma binding of propranolol to ethnic differences in sensitivity. Comparison between Chinese and CaucasiansH H Zhou, S D Shay, A J WoodZhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|September 1, 1996
Inhibition of imipramine N-demethylation by fluvoxamine in Chinese young menZ H Xu, S L Huang, H H ZhouPageof 11